✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

KMS Medisurgi Ltd.

KMSMEDI

Market Cap
₹41 Cr.
P/E
72.00

KMS Medisurgi Ltd.

  • KMS Medisurgi
  • Amkay Products
  • GKB Ophthalmics
FAQs on KMS Medisurgi Ltd. Shareprice

KMS Medisurgi has given better returns compared to its competitors.
KMS Medisurgi has grown at ~32.86% over the last 5yrs while peers have grown at a median rate of 20.0%

KMS Medisurgi is not expensive.
Latest PE of KMS Medisurgi is 72.0, while 3 year average PE is 79.27.
Also latest EV/EBITDA of KMS Medisurgi is 0 while 3yr average is 24.46.

View FAQ's On Business
Growth Table
  • KMS Medisurgi Ltd.
  • Amkay Products
  • GKB Ophthalmics
Balance Sheet
  • KMS Medisurgi Ltd.
  • Amkay Products
  • GKB Ophthalmics
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • KMS Medisurgi Ltd.
  • Amkay Products
  • GKB Ophthalmics
Cash Flow
  • KMS Medisurgi Ltd.
  • Amkay Products
  • GKB Ophthalmics
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • KMS Medisurgi Ltd.
  • Amkay Products
  • GKB Ophthalmics
Quarterly Results
  • KMS Medisurgi Ltd.
  • Amkay Products
  • GKB Ophthalmics
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on KMS Medisurgi Ltd. Financials

Balance sheet of KMS Medisurgi is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of KMS Medisurgi is increasing.
Latest debt of KMS Medisurgi is ₹0.52 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹0.29 Crs.

The profit is oscillating.
The profit of KMS Medisurgi is ₹0.45 Crs for Mar 2024, ₹0.57 Crs for Mar 2023 and ₹0.22 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
KMS Medisurgi latest dividend payout ratio is 3.64% and 3yr average dividend payout ratio is 4.73%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech